SCHEMBL7467654

SCHEMBL7467654

COc1nc2cc(C)c(Cl)c(NS(C)(=O)=O)c2nc1OC

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY1R P25929 2/20 0.37
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37
HIF1A Q16665 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
PIK3CA P42336 3/20 0.35
CCR4 P51679 6/20 0.33
FFAR4 Q5NUL3 1/20 0.33
SCN9A Q15858 2/20 0.32
PIK3CD O00329 3/20 0.32
PIK3CB P42338 1/20 0.32
PIK3CG P48736 1/20 0.32
SLC22A1 O15245 1/20 0.32
ABCC4 O15439 1/20 0.32
KDM1A O60341 1/20 0.32
NR1I2 O75469 1/20 0.32
TP53 P04637 1/20 0.32
CYP1A2 P05177 1/20 0.32
GLA P06280 1/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7466587 0.89 CCR4 (0.36) NPY1RALDH1A1GAAHIF1ASMN1; SMN2
SCHEMBL7468793 0.88 CCR4 (0.36) NPY1RALDH1A1GAAHIF1ASMN1; SMN2
SCHEMBL7468982 0.87 ALDH1A1 (0.45) NPY1RALDH1A1GAAHIF1ASMN1; SMN2
SCHEMBL7465420 0.85 SMN1; SMN2 (0.33) NPY1RALDH1A1GAAHIF1ASMN1; SMN2
SCHEMBL7476942 0.85 ALDH1A1 (0.38) NPY1RALDH1A1GAAHIF1ASMN1; SMN2
SCHEMBL7475650 0.84 CCR4 (0.35) PIK3CACCR4PIK3CDPIK3CBPIK3CG
SCHEMBL8935311 0.82 SMN1; SMN2 (0.32) NPY1RALDH1A1GAAHIF1ASMN1; SMN2
SCHEMBL7470948 0.79 GLP1R (0.33) NPY1RALDH1A1GAAHIF1ASMN1; SMN2
SCHEMBL7472769 0.78 NQO2 (0.33) NPY1RALDH1A1GAAHIF1ASMN1; SMN2
SCHEMBL7462801 0.76 CCR4 (0.36) HIF1ASMN1; SMN2PIK3CACCR4PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0783495-B1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER LTD (GB) 2002-02-27 EP disclosed
US-5863917-A ANXIOLYTIC AGENT, ANTICONVULSANTS, ANALGESICS AND NEUROPROTECTIVES. PFIZER, INC. (US) 1999-01-26 US disclosed
US-5852016-A Quinoxaline derivatives useful in therapy PFIZER INC. (US) 1998-12-22 US disclosed
WO-1997031902-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-04 WO disclosed
EP-0792874-A1 Quinoxaline derivatives useful in therapy Pfizer Limited (GB) 1997-09-03 EP disclosed
EP-0783495-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY Pfizer Limited (GB) 1997-07-16 EP disclosed
WO-1996009295-A1 QUINOXALINE DERIVATIVES USEFUL IN THERAPY PFIZER LIMITED (GB) 1996-03-28 WO disclosed